Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity
Abstract Suppressing immune responses promotes allograft survival but also favours tumour progression and recurrence. Selectively suppressing allograft rejection while maintaining or even enhancing antitumor immunity is challenging. Here, we show loss of allograft-related rejection in mice deficient...
Saved in:
| Main Authors: | Xiaosheng Tan, Xiangli Zhao, Zunsong Hu, Ding-Sheng Jiang, Zhibo Ma, Lingjuan Sun, Jingzeng Wang, Xia Huang, Bin Xie, Mi Wu, Min Ma, Cong-Yi Wang, Shu Zhang, Li Chen, Zhishui Chen, Gang Chen, Peixiang Lan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-58841-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy
by: Zhishui Chen, et al.
Published: (2024-01-01) -
The function of histone methyltransferase SETDB1 and its roles in liver cancer
by: Enxiang Zhang, et al.
Published: (2024-11-01) -
SETDB1 promotes mammalian liver regeneration by stimulating cytokine CSF3 in hepatocytes
by: Xiao-Yan Huang, et al.
Published: (2025-06-01) -
Targeting SETDB1 in cancer and immune regulation: Potential therapeutic strategies in cancer
by: Bo‐Syong Pan, et al.
Published: (2025-03-01) -
Tnfa-setdb2 Pathway Regulates Fibroblast to Myofibroblast Transition in Wound Repair
by: Tyler M. Bauer, et al.
Published: (2024-01-01)